E. Andrew

660 total citations
35 papers, 535 citations indexed

About

E. Andrew is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Nephrology. According to data from OpenAlex, E. Andrew has authored 35 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Materials Chemistry and 7 papers in Nephrology. Recurrent topics in E. Andrew's work include Lanthanide and Transition Metal Complexes (9 papers), Cardiac Imaging and Diagnostics (7 papers) and Acute Kidney Injury Research (7 papers). E. Andrew is often cited by papers focused on Lanthanide and Transition Metal Complexes (9 papers), Cardiac Imaging and Diagnostics (7 papers) and Acute Kidney Injury Research (7 papers). E. Andrew collaborates with scholars based in Norway, United States and Switzerland. E. Andrew's co-authors include M. G. Svaland, D. Hoefnagel, William O. Berndt, Jon Ø. Nossen, K. J. Berg, Petter‐Arnt Hals, Tanweer Haider, Jarl Å. Jakobsen, K. Levorstad and T Aakhus and has published in prestigious journals such as New England Journal of Medicine, Radiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

E. Andrew

34 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Andrew Norway	13	147	139	91	76	74	35	535
Harald Johnsen Norway	13	156 1.1×	121 0.9×	65 0.7×	39 0.5×	98 1.3×	23	666
Suh‐Young Lee South Korea	19	57 0.4×	44 0.3×	80 0.9×	37 0.5×	87 1.2×	72	987
Paul McPherson United States	11	271 1.8×	120 0.9×	183 2.0×	8 0.1×	208 2.8×	25	955
Karolina M. Zaręba United States	15	40 0.3×	371 2.7×	116 1.3×	14 0.2×	74 1.0×	40	1.2k
William P. Thorpe United States	9	39 0.3×	53 0.4×	99 1.1×	37 0.5×	586 7.9×	15	1.2k
Martín Jc Spain	17	83 0.6×	22 0.2×	42 0.5×	55 0.7×	160 2.2×	54	688
Francesca Martino Italy	14	236 1.6×	25 0.2×	32 0.4×	24 0.3×	40 0.5×	48	486
John M. Gemery United States	11	50 0.3×	42 0.3×	15 0.2×	30 0.4×	54 0.7×	23	386
E Alhava Finland	14	26 0.2×	44 0.3×	23 0.3×	51 0.7×	51 0.7×	29	437
Suzanne El‐Sayegh United States	15	187 1.3×	53 0.4×	62 0.7×	5 0.1×	141 1.9×	62	706

Countries citing papers authored by E. Andrew

Since Specialization

Citations

This map shows the geographic impact of E. Andrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Andrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Andrew more than expected).

Fields of papers citing papers by E. Andrew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Andrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Andrew. The network helps show where E. Andrew may publish in the future.

Co-authorship network of co-authors of E. Andrew

This figure shows the co-authorship network connecting the top 25 collaborators of E. Andrew. A scholar is included among the top collaborators of E. Andrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Andrew. E. Andrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bjørnaas, Mari Asphjell, Knut Erik Hovda, E. Andrew, et al.. (2006). Clinical vs. Laboratory Identification of Drugs of Abuse in Patients Admitted for Acute Poisoning. Clinical Toxicology. 44(2). 127–134. 20 indexed citations

Svaland, M. G., et al.. (1998). Late allergy-like reactions following vascular administration of radiography contrast media. Acta Radiologica. 39(4). 344–348. 26 indexed citations

Nossen, Jon Ø., et al.. (1995). Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function. Scandinavian Journal of Clinical and Laboratory Investigation. 55(4). 341–350. 31 indexed citations

Andrew, E. & Thomas Haider. (1993). Incidence of Roentgen Contrast Medium Reactions after Intravenous Injection in Pre-Registration Trials and Post-Marketing Surveillances. Acta Radiologica. 34(3). 210–213. 5 indexed citations

Øksendal, A. N., et al.. (1993). Oral Magnetic Particles. Acta Radiologica. 34(2). 187–193. 12 indexed citations

Svaland, M. G., et al.. (1992). Human Pharmacokinetics of Iodixanol. Investigative Radiology. 27(2). 130–133. 73 indexed citations

Bolstad, B., K. W. Borch, Birthe H. Grynne, et al.. (1991). Safety and Tolerability of Iodixanol: A Dimeric, Nonionic Contrast Medium: An Emphasis on European Clinical Phases I and II. Investigative Radiology. 26. S201–S204. 33 indexed citations

Nossen, Jon Ø., et al.. (1990). Experience with Iodixanol, a New Nonionic Dimeric Contrast Medium Preliminary Results From the Human Phase I Study. Investigative Radiology. 25. S113–S114. 39 indexed citations

Andrew, E., et al.. (1990). Publications on clinical trials with X-ray contrast media: differences in quality between journals and decades. European Journal of Radiology. 10(2). 92–97. 11 indexed citations

10.

Hagve, Tor‐Arne, et al.. (1989). Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.. PubMed. 9(4). 203–7. 5 indexed citations

11.

Andrew, E., et al.. (1988). Clinical Trial Program for Iopentol A New Nonionic Ratio 3.0 Contrast Medium with Emphasis on Clinical Phases I and II. Investigative Radiology. 23. S189–S192. 6 indexed citations

12.

Matheson, I, et al.. (1987). Excretion of Iohexol and Metrizoate in Human Breast Milk. Acta Radiologica. 28(5). 523–526. 19 indexed citations

13.

Andrew, E., et al.. (1987). Pharmacokinetics of iopentol in healthy volunteers.. PubMed. 370. 113–7. 9 indexed citations

14.

Haider, Thomas, et al.. (1987). Adverse Reactions following Two Separate Intravascular Injections of Contrast Media in the Same Patient. Acta Radiologica. 28(1). 93–97. 4 indexed citations

15.

Andrew, E., et al.. (1985). Omnipaque and Urografin in Left Ventriculography and Coronary Arteriography. A Randomised, Double Blind Study. British Journal of Radiology. 58(688). 319–323. 9 indexed citations

16.

Andrew, E., et al.. (1985). Intravascular studies with iohexol (Omnipaque). Results from the first 49 clinical trials.. PubMed. 5(1). 68–76. 10 indexed citations

17.

Orning, Otto M., et al.. (1984). Iohexol in Coronary Angiography. Acta Radiologica Diagnosis. 25(3). 243–248. 4 indexed citations

18.

Andrew, E.. (1984). Method for Assessment of the Reporting Standard of Clinical Trials with Roentgen Contrast Media. Acta Radiologica Diagnosis. 25(1). 55–58. 19 indexed citations

19.

Andrew, E.. (1984). Evaluation of the Vascular Clinical Trial Program of Metrizamide and Iohexol. Acta Radiologica Diagnosis. 25(1). 59–64. 1 indexed citations

20.

Andrew, E., et al.. (1983). Iohexol in phlebography of the leg. A comparative investigation with meglumine metrizoate.. PubMed. 366. 65–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact